Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 812-963-1 | CAS number: 178436-06-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute toxicity: oral
- Key study, read-across, source substance Ceramide III, OECD guideline 401 and EU Method B.1, GLP, Reliability 1: Oral LD50 (rat) > 5000 mg/kg bodyweight
- Supporting study, target substance Ceramide IIIB, similar to OECD guideline 401, Reliability 2: Oral LD50 (rat) > 2000 mg/kg bodyweight
Acute toxicity: dermal
- Key study, target substance Ceramide IIIB, similar to OECD guideline 402, Reliability 2: Dermal LD50 (rat) > 2000 mg/kg bodyweight
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1992-02-05 to 1992-02-19
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- adopted February 24, 1987.
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Version / remarks:
- September 1984
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Specific details on test material used for the study:
- The formulations were prepared immediately prior to dosing. The test substance was weighed into a glass flask on an analytical balance and the vehicle (w/w) was added. Adjustment was made for specific gravity of vehicle. Homogeneity of the test substance in vehicle was obtained using a homogeniser and a spatula.
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: BRL Ltd., Basel, Switzerland
- Age at study initiation: approx. 8 weeks
- Weight at study initiation: Male= 198 to 209 g, female= 150 to 164 g
- Fasting period before study: yes, feed was withheld overnight prior to dosing until approximately 3-4 hours after administration of the test substance.
- Housing: Collection caging in polycarbonate cages / max. 5 rats
- Diet (e.g. ad libitum): laboratory animal diet (KLIB 343 from Klingentalmühle AG, Kaiseraugst, Switzerland)
- Water (e.g. ad libitum): ad libitum, tap water
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 °C
- Humidity (%): 55 %
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 hours daily - Route of administration:
- oral: gavage
- Vehicle:
- propylene glycol
- Details on oral exposure:
- Dose volume: 10 mL/kg bw
DOSAGE PREPARATION: 5000 mg/kg bw were achieved by administration of two times 2500 mg/kg bw - Doses:
- 5000 mg/kg bw, given as 2 dosages of 2500 mg/kg bw within 24 hours. Multiple dosages given within 24 hours are regarded as a single dose.
- No. of animals per sex per dose:
- 5 males, 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations:
mortality: twice daily
clinical signs: 0, 2, 4 h, daily thereafter
- Frequency of weighing: Days 1 (pre-administration), 8 and 15
- Necropsy of survivors performed: yes - Preliminary study:
- -Pilot study with three groups, each comprising of 1 male and 1 female rat
-orally dosed with test material in propylene glycol at 5000 (2x2500 within 24 hours), 2000 or 1000 mg/kg body weight
- no animal died. - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- act. ingr.
- Mortality:
- No mortality occurred.
- Clinical signs:
- other: Signs of ill health or behavioural changes included ataxia only observed in all animals approximately 2 hours after each dosing.
- Gross pathology:
- Macroscopic post mortem examination of the surviving animals at termination did not reveal any abnormalities that were not commonly noted among rats of this age and strain or that were considered toxicologically significant. Pelvic dilation (left and right kidney) in a single female rat was considered not to be related to the treatment.
- Other findings:
- None reported.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this acute oral toxicity study, the oral LD50 value of the test item in rats of either sex was exceeding 5000 mg/kg bodyweight.
- Executive summary:
In an acute oral toxicity study according to OECD guideline 401 (adopted February 24, 1987) and EU Method B.1 (September 1984), 5 male and 5 female, fasted, 8-9 weeks old Wistar strain rats were given a single oral dose of Ceramide III in propylene glycol by gavage at a dose of 5000 mg/kg bw and daily observed for 14 days. Body weight was determined at day 1 (pre-administration), 8 and 15.
Ceramide III was administered as 2 dosages of 2500 mg/kg bw within 24 hours. Multiple dosages given within 24 hours are regarded as a single dose.
No animal died. Apart from ataxia noted after each dosing, no other signs of ill health or behavioural changes were observed during the study period and no macroscopic toxicologically significant abnormalities were noted at necropsy at the end of the experimental period.
Oral LD50 (rat) > 5000 mg/kg bodyweight
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- Between 1995-01-03 and 1995-01-19
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- only basic data given; experimental period 8 days; only 4 animals tested
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- only 4 animals tested, experimental period only 8 days
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- no information available
- Route of administration:
- oral: gavage
- Vehicle:
- propylene glycol
- Details on oral exposure:
- Dose volume: 10 mL/kg bw
- Doses:
- 2000 mg/kg body weight (dose volume 10 ml/kg body weight)
- No. of animals per sex per dose:
- 2 males, 2 females
- Control animals:
- no
- Details on study design:
- Animals were subjected to daily observations and determination of body weight at start and termination. Macroscopic examination of the animals was performee at the end of the experimental period (day 8).
- Preliminary study:
- Not reported.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- act. ingr.
- Mortality:
- No mortality occurred.
- Clinical signs:
- other: All animals showed slightly uncoordinated movements two and four hours after treatment. Piloerection was observed in a single female animal two hours after treatment.
- Gross pathology:
- Macroscopic post mortem examination of the surviving animals at termination did not reveal any abnormalities that were not commonly noted among rats of this age and strain or that were considered toxicologically significant.
- Other findings:
- none reported.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this acute oral toxicity study, the oral LD50 value of the test item in rats of either sex was exceeding 2000 mg/kg bodyweight.
- Executive summary:
In an acute oral toxicity study similar to OECD guideline 401, 2 male and 2 female Wistar strain rats were given a single oral dose of Ceramide IIIB in propylene glycol by gavage at a dose of 2000 mg/kg bodyweight. The animals were observed daily for a period of 8 days. Body weight gain was determined.
No animal died. Apart from uncoordinated movements and piloerection after dosing, no other signs of ill health or behavioural changes were observed during the study period and no macroscopic toxicological significant abnormalities were noted at necropsy at the end of the experimental period.
Oral LD50 (rat) > 2000 mg/kg bw
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Two reliable study reports on acute oral toxicity prove that the given data are of high quality.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Between 1995-01-03 and 1995-01-19
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- only basic data given; experimental period only 8 days; only 4 animals tested
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- yes
- Remarks:
- experimental period 8 days only, only 4 animals tested
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- no information available
- Type of coverage:
- not specified
- Vehicle:
- propylene glycol
- Details on dermal exposure:
- no information given
- Duration of exposure:
- no information given
- Doses:
- 2000 mg/kg body weight
- No. of animals per sex per dose:
- 2 males and 2 females
- Control animals:
- not specified
- Details on study design:
- One group of Wistar rats, consisting of two males and two females, received a single dermal application of the test substance suspended in propylene glycol at a dose level of 2000 mg/kg body weight (dose volume 10 mL/kg body weight).
Animals were subjected to daily observations and determination of body weight at start and termination.
Macroscopic examination of the animals was performed at the end of the experimental period (day 8). - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occurred.
- Clinical signs:
- other: No clinical signs were observed.
- Gross pathology:
- No abnormalities were found at macroscopic examination of the animals.
- Other findings:
- None described.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- According to this study, the dermal LD50 value of the test substance for both males and females was considered to exceed 2000 mg/kg body weight.
- Executive summary:
In an acute dermal toxicity study similar to OECD guideline 402, 2 male and 2 female Wistar strain rats were given a single dose of Ceramide IIIB suspended in propylene glycol at a dose level of 2000 mg/kg body weight (dose volume 10 mL/kg body weight). Animals were subjected to daily observations and determination of body weight at start and termination. Macroscopic examination of the animals was performed at the end of the experimental period (day 8).
No animal died. No effect on body weight gain was observed. No clinical signs were observed during the study period and no macroscopic toxicological significant abnormalities were noted at necropsy at the end of the experimental period.
Dermal LD50 (rat) > 2000 mg/kg bw
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The given report contains basic information, but the outcome of the acute dermal toxicity study is strongly supported by the results from acute oral toxicity studies.
Additional information
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.